Molina Healthcare guidance and Medicaid focus, shares in S&P 500 spotlight
26.06.2026 - 11:55:42 | ad-hoc-news.de
By Julia Schmitt, Sector & Peer Group desk. Reviewed prior to publication on 2026-06-26, 11:55.
Molina Healthcare (US60855R1005) continues to pursue a focused Medicaid and government-sponsored health plan strategy in the United States. The S&P 500 constituent competes with UnitedHealth Group and Centene in managed care, and recent filings confirm its current-year guidance and emphasis on disciplined growth in core contracts. Latest Form 10-Q filed with the SEC
What the latest figures show
Molina Healthcare reported first-quarter 2024 revenue of about 9.93 billion dollars, up roughly 17 percent year on year, with net income of around 321 million dollars according to the company’s April 24 earnings release. Molina Healthcare Q1 2024 earnings release The insurer highlighted membership growth in Medicaid and Medicare segments, continuing the pattern of multi-year premium expansion.
The company reaffirmed full-year 2024 adjusted earnings outlook around mid-teens earnings growth versus 2023 levels, backed by stable medical cost ratios and a strong pipeline of state contracts in its core markets per management commentary. Bloomberg report on Molina guidance and reaction This guidance confirmation anchors investor expectations in the health insurance space, which has seen mixed sentiment around utilization trends.
Analyst views and peer comparison
Analyst consensus compiled by MarketScreener shows a majority of coverage on Molina Healthcare with Buy or Outperform ratings, and an average 12-month price target above the current share price. MarketScreener consensus on Molina Healthcare This compares with similarly constructive views on peers UnitedHealth Group and Centene, although Molina’s narrower focus on Medicaid gives it a more specialized risk and growth profile.
Commentary from major houses such as JPMorgan and UBS in recent months has underscored the resilience of Medicaid enrollment and premium trends for Molina, while noting watchpoints around potential rate adjustments and policy changes at the state and federal levels. Reuters analysis on U.S. health insurers and Medicaid In that context, Molina’s reaffirmed guidance and stable medical costs are viewed as consistent rather than surprising, supporting a steady equity story.
Background and price data on Molina Healthcare
All reports, regulatory filings and price information on Molina Healthcare are collected in the dedicated topic section.
The business behind the stock
Molina Healthcare’s business centers on providing health insurance products to individuals and families under government programs such as Medicaid, Medicare and state-based health insurance marketplaces. The company administers managed care plans where it receives fixed per-member-per-month premiums and aims to control medical costs while delivering access to care.
Where the stock trades today
The Molina Healthcare shares (US60855R1005) trade on the New York Stock Exchange at around 520 dollars as of 2026-06-26, 09:30 Eastern Time, reflecting a market capitalization near 30 billion dollars.
Key data on the Molina Healthcare shares
- Company: Molina Healthcare, Inc.
- ISIN: US60855R1005
- WKN: A0YHVL
- Ticker: MOH
- Trading venue: NYSE
- Price (as of 2026-06-26, 09:30): 520.00 USD
- Market cap: 30,000,000,000 USD (as of 2026-06-26)
- Sector / industry: Health Care / Managed Care
- Index membership: S&P 500
- Next earnings date: 2024-07-24
Disclaimer: This article is for informational purposes only and does not constitute investment advice, a recommendation or an offer to buy or sell any securities. All data are based on sources believed to be reliable but may be subject to change.
